TL;DR
This paper introduces HIT-scISOseq, a novel method that significantly boosts the throughput and accuracy of single-cell full-length isoform sequencing. By overcoming limitations of existing long-read technologies, HIT-scISOseq enables a more comprehensive understanding of cellular transcriptomes, revealing novel isoforms and complex splicing events previously inaccessible.
What Problem Does This Paper Address?
Single-cell RNA sequencing (scRNA-seq) has revolutionized our ability to study cellular heterogeneity. However, traditional short-read scRNA-seq technologies are limited in their ability to resolve complex transcript isoforms, alternative splicing, and chimeric transcripts. While long-read sequencing technologies offer the potential to capture full-length transcripts, they have historically suffered from low throughput and high error rates, making them expensive and difficult to scale for large single-cell studies. This paper addresses the critical need for a high-throughput, high-accuracy, and cost-effective method for single-cell full-length isoform sequencing.
Methods
The core innovation of HIT-scISOseq lies in its two-phase approach:
- Capture Phase: To mitigate artifacts common in 10x Genomics library preparation (specifically, template-switching oligonucleotide or TSO artifacts), the researchers developed a biotinylated PCR primer strategy. This primer captures desirable full-length cDNAs, allowing for their enrichment via streptomycin magnetic beads. This effectively reduces TSO artifacts from ~50% to less than 8%.
- Concatenation Phase: To maximize the utility of PacBio's long-read sequencing capacity, the researchers devised a novel library preparation method. This involves ligating multiple full-length cDNA molecules end-to-tail to create a single, long SMRTbell insert. This "concatenation" approach allows for more efficient sequencing on PacBio's Sequel II platform, yielding significantly more data per SMRT cell.
Additionally, the authors developed a custom computational pipeline, "scISA-Tools," specifically designed to process the linked transcript reads generated by HIT-scISOseq, which are not compatible with standard IsoSeq3 pipelines.
Datasets
The primary dataset used for demonstrating HIT-scISOseq's capabilities comes from cynomolgus monkey corneal epitheliums. The study analyzed approximately 4,000 normal and 8,000 injured corneal epithelial cells. The authors also performed cross-platform validation using Illumina short-read RNA sequencing (NGS) on the same single-cell 10x Genomics cDNA samples.
Key Insights and Ideas
- Bridging the Gap: HIT-scISOseq effectively bridges the gap between the high throughput of short-read sequencing and the isoform-resolution capabilities of long-read sequencing, offering the best of both worlds.
- Artifact Reduction is Crucial: The significant reduction in TSO artifacts is a key enabler for improving data quality and downstream analysis accuracy.
- Concatenation is Key for Throughput: The clever concatenation of multiple transcripts into a single long read is a critical innovation for maximizing data output from expensive long-read sequencing platforms.
- Unveiling the "Dark Matter" of the Transcriptome: By enabling high-resolution isoform analysis, HIT-scISOseq can reveal novel isoforms and complex splicing events that are often missed by short-read methods, providing a deeper understanding of gene regulation and function.
Key Results
- Throughput Boost: HIT-scISOseq generates over 10 million high-accuracy full-length isoforms from a single PacBio Sequel II 8M SMRT Cell, representing an 8-fold increase in data output compared to standard single-cell isoform sequencing protocols.
- Artifact Reduction: The method reduces TSO artifacts from ~50% to <8%.
- High Accuracy: The method achieves high accuracy, with mapped FLNC reads showing high mappability (>98%) and mapping identity (>97%).
- Comprehensive Transcriptome Profiling: The study successfully profiled transcriptomes of thousands of corneal epithelial cells, identifying cell-type-specific expression patterns, novel isoforms, and injury-related splicing events.
- Cross-Platform Concordance: HIT-scISOseq data showed strong concordance with Illumina NGS data in terms of gene expression quantification and cell-type classification.
Limitations and Future Work
- Concatenation Length Optimization: The authors found that while longer concatenations are possible, they increase the risk of irreversible cDNA damage (nicks), which can impair polymerase performance. They optimized their system for ~5 kb concatenations (2-3 full-length transcripts) to balance length and quality. Future work could focus on further optimizing input quality by reducing DNA nicks and exploring size selection methods for longer concatenated molecules.
- Broader Applicability: While the study focused on mRNA, the authors suggest that the HIT-scISOseq approach could be adapted to target other RNA species like LncRNA or eccRNA by altering concatenation library composition.
- Multiplexed Analysis: The high accuracy and throughput of HIT-scISOseq make it suitable for multiplexed single-cell RNA-sequencing of pooled individuals, enabling the study of natural polymorphisms and sample identification.
- Platform Adaptability: HIT-scISOseq is compatible with commercially available 10x Genomics platforms and is expected to be adaptable to other microwell-based and combinatorial-indexing technologies.
Summary updated